BATS BZX Real-Time Price
As of 9:45am ET
| +0.01 / +0.25%|
The 6 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +124.44% increase from the last price of 4.01.
The current consensus among 7 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.